Trials / Conditions / Gastrointestinal Cancer Metastatic

Gastrointestinal Cancer Metastatic

9 registered clinical trials studyying Gastrointestinal Cancer Metastatic — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma NCT07529808	BigHat Biosciences, Inc.	Phase 1 / Phase 2
Withdrawn	Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers NCT05359042	University of California, San Francisco	N/A
Recruiting	MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes NCT04534543	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A
Completed	A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Help NCT05087992	Boehringer Ingelheim	Phase 1
Recruiting	Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643	Cedars-Sinai Medical Center	N/A
Completed	A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer NCT03343301	Five Prime Therapeutics, Inc.	Phase 1
Unknown	Drug Sensitivity Screening for Gastrointestinal Cancer NCT04298489	Peking University Cancer Hospital & Institute	N/A
Recruiting	Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer NCT02174549	Teclison Ltd.	Phase 1 / Phase 2
Completed	5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lu NCT01658813	Western Regional Medical Center	Phase 2